v3.26.3
EQUITY (Tables)
9 Months Ended
Sep. 30, 2026
Equity [Abstract]  
Schedule of Warrants Outstanding and Exercisable The following table summarizes the status of warrants and related transactions:
Non-Derivative (Equity) Warrants
Derivative Liabilities Warrants
Total Number of WarrantsWeighted - Average Exercise Price
Balance as of January 1, 2026
57,994,08721,400,00079,394,087$0.95 
Granted100,000 — 100,000 $0.48 
Balance as of September 30, 2026
58,094,08721,400,00079,494,087$0.95 
Exercisable as of September 30, 2026
56,874,08721,400,00078,274,087$0.95 
Schedule of Share-Based Payment Award, Warrants, Valuation Assumptions The following assumptions were used for the calculation at date of issuance:
Weighted average stock price$0.49
Weighted average expected stock price volatility106.4%
Expected annual dividend yield0%
Weighted average expected life of warrants
5.0 years
Weighted average risk-free annual interest rate4.2%
Weighted average grant date fair value$0.39
Schedule of Stock Options Outstanding
The following table summarizes the status of stock options and related transactions:
Number of Stock OptionsWeighted-Average Per Share Exercise Price
Issued and Outstanding as of January 1, 202626,597,918 $0.75 
Granted635,000 $0.52 
Exercised
(11,666)$0.46 
Cancelled/forfeited/expired(200,000)$0.64 
Issued and Outstanding as of September 30, 202627,021,252 $0.74 
Exercisable as of September 30, 202621,261,558 $0.80 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions The following assumptions were used for the calculation at date of grant:
Nine Months Ended September 30,
20262025
Weighted average stock price$0.52$0.41
Weighted average expected stock price volatility104.1%92.8%
Expected annual dividend yield0%0%
Weighted average expected life5.4 years5.1 years
Weighted average risk-free annual interest rate4.5%3.9%
Weighted average grant date fair value$0.41$0.30
Schedule of Components of Share-based Compensation Expense
The components of share-based compensation expense, net, are as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Stock options expense$227 $261 $747 $187 
Restricted stock— — 68 — 
Warrants60 96 176 237 
Total share-based compensation expense, net$287 $357 $991 $424